The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

RAS/RAF Mutations and New Approaches in CRC: Onvansertib+Irinotecan for KRASm, Enco+Bini+Cetux in BRAF V600Em, NGS in mCRC

9 views
May 17, 2021
0 Comments
Login to view comments. Click here to Login
2021 KUMC Virtual Multidisciplinary Oncology Review